Education
About Us
Working with TipRanks
Follow Us
Nicholas Grund Insider Profile
4 Followers
Nicholas Grund, CCO at Amag Pharmaceuticals, holds 442.58K shares in Akebia Therapeutics (Ticker: AKBA), holds 84.81K shares in Amag Pharmaceuticals (Ticker: AMAG).
Nicholas Grund Amag Pharmaceuticals (AMAG)CCO
Amag Pharmaceuticals (AMAG)
CCO
Not Ranked
Nicholas Grund has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Roles
CCO
Roles that Nicholas Grund holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Nicholas Grund
Nicholas Grund's Trading History
Amag Pharmaceuticals
Mar 05, 2019
―
Uninformative Sell
14.49K
$1.17M
Akebia Therapeutics
Feb 04, 2025
CCO
Uninformative Buy
―
$840.90K
List of latest transactions for each holding click on a transaction to see Nicholas Grund's performance on stock
You May Also Like
Nicholas Grund insider profile FAQ
What is the percentage of profitable transactions made by Nicholas Grund?
The percentage of profitable transactions made by Nicholas Grund is ―.
What is the average return per transaction made by Nicholas Grund?
The average return per transaction made by Nicholas Grund is ―.
What stocks does Nicholas Grund hold?
Nicholas Grund holds: AMAG, AKBA stocks.
What was Nicholas Grund’s latest transaction?
Nicholas Grund latest transaction was an Uninformative Buy of ―.
What was Nicholas Grund's most profitable transaction?
Nicholas Grund’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Nicholas Grund's role in Amag Pharmaceuticals?
Nicholas Grund's role in Amag Pharmaceuticals is CCO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.